State of Wisconsin Investment Board’s Audentes Therapeutics, Inc BOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-115,600
Closed -$6.92M 1774
2019
Q4
$6.92M Buy
115,600
+50,000
+76% +$1.88M 0.02% 826
2019
Q3
$1.84M Buy
65,600
+11,400
+21% +$389K 0.01% 1033
2019
Q2
$2.05M Buy
54,200
+1,200
+2% +$46.1K 0.01% 1015
2019
Q1
$2.07M Buy
53,000
+19,500
+58% +$559K 0.01% 999
2018
Q4
$714K Buy
33,500
+900
+3% +$23.2K ﹤0.01% 1225
2018
Q3
$1.29M Hold
32,600
﹤0.01% 1123
2018
Q2
$1.25M Buy
32,600
+21,600
+196% +$800K ﹤0.01% 1090
2018
Q1
$331K Hold
11,000
﹤0.01% 1353
2017
Q4
$344K Hold
11,000
﹤0.01% 1341
2017
Q3
$308K Hold
11,000
﹤0.01% 1368
2017
Q2
$210K Buy
+11,000
New +$176K ﹤0.01% 1398

State of Wisconsin Investment Board's BOLD Position: Q1 2020 in Review

State of Wisconsin Investment Board sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 115,600 shares — an estimated $6.92M sold.

State of Wisconsin Investment Board first reported a position in BOLD in Q2 2017 and held it in 11 quarters. The position peaked at $6.92M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • State of Wisconsin Investment Board reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 115,600 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $6.92M.
  • State of Wisconsin Investment Board first reported a position in Audentes Therapeutics, Inc in Q2 2017 and held it in 11 quarters.
  • State of Wisconsin Investment Board's Audentes Therapeutics, Inc position peaked at $6.92M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2020, filed 6 May 2020.